A detailed history of Whittier Trust CO Of Nevada Inc transactions in Genmab A/S stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 188 shares of GMAB stock, worth $3,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188
Previous 188 -0.0%
Holding current value
$3,870
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

BUY
$27.94 - $35.44 $2,374 - $3,012
85 Added 82.52%
188 $5,000
Q1 2023

Apr 21, 2023

BUY
$34.88 - $43.22 $3,592 - $4,451
103 New
103 $3,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.